Initial Statement of Beneficial Ownership - Kalawadia Milan Kantilal

This filing reports the initial statement of beneficial ownership for Kalawadia Milan Kantilal, CEO of North America for DR REDDYS LABORATORIES LTD. The report, filed on April 1, 2026, pertains to the period of December 18, 2025. Mr. Kantilal directly owns 47,325 equity shares underlying ADRs. The filing is made in accordance with SEC regulations, specifically Form 3, which requires insiders to report their beneficial ownership of securities.